OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
- OrthoPediatrics reported a quarterly loss of $0.30 per share, beating estimates by 28.57%. - Revenues for the quarter were $44.69 million, exceeding expectations by 7.35%. - The stock has added 1% YTD compared to the S&P 500's 7.5% gain. - The company's earnings outlook indicates a Zacks Rank #3 (Hold). - Industry rank for Medical - Instruments is in the bottom 41% of Zacks industries. Price Impact Rating: bearish Impact Horizon Rating: short-term Type: Research Analysis
View signal analysis